SXTP - 60 Degrees Pharmaceuticals, Inc. Common Stock
60 Degrees Pharmaceuticals, Inc. Common Stock Logo

SXTP - 60 Degrees Pharmaceuticals, Inc. Common Stock

https://www.60degreespharma.com
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot

60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases. The company is headquartered in Washington, District of Columbia.

52W High
$12.45
52W Low
$1.22
MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
2.73
Valuation
Fair
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
20.14
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
22.23
EV/Revenue (<3 favorable)
21.11
P/S (TTM) (<3 favorable)
5.88
P/B (<3 favorable)
N/A
Ownership
Retail‑heavy
Source: Overview
Insiders (1–5% typical)
2.96%
Institutions (25–75% balanced)
12.89%
Shares Outstanding
4,104,500
Float
3,728,200
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
984,490
Gross Profit (TTM)
179,110
EPS (TTM)
0.07
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
-5.21%
ROE (TTM) (>15% strong)
-2.95%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
1.45
Momentum
Value
N/A
Previous
N/A
Trend
—
Signal Cross
No cross
As of
—